MedTrace Logo

Validation and Reliability of the Turkish 4AT Scale for Post-Anesthesia Awakening Delirium

NCT06187389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 188

Last updated 2024-01-02

No results posted yet for this study

Summary

Background: Delirium is a common and serious condition in hospitalized patients that often leads to extended hospital stays and increased healthcare costs. Accurate and timely detection is essential for optimal patient outcome.

Aims: This study aimed to adapt the internationally recognized 4 AT Delirium Diagnosis Scale to Turkish and to evaluate the validity and reliability of this tool for the Turkish patient population.

Design: This study was structured and conducted at a state hospital from March to June 2023.

Methods: The study included 188 participants, determined through a power analysis. The 4AT Delirium Test and additional assessment tools were used to ascertain the delirium status of the patients. Comprehensive statistical evaluations were conducted using SPSS 25.0, which included analyses, such as item difficulty indices, item discrimination, and chi-square tests. Ethical approval for this study was granted by the Non-Interventional Ethics Committee, ensured full compliance with the ethical standards set by the World Medical Association's Declaration of Helsinki. All participants provided informed consent before participation. Additionally, our results strictly adhered to the guidelines of the STROBE Checklist.

Conditions

  • Delirium
  • Awakening, Post-Anesthesia Delayed
  • Delirium, Postoperative
  • Nurse's Role
  • Nursing Caries

Interventions

OTHER

1 Grups

This methodological study was conducted using a cross-sectional observational approach at a leading teaching and research hospital. The study duration was from March to June 2023

Sponsors & Collaborators

  • Kilis 7 Aralik University

    lead OTHER

Principal Investigators

  • islam elagöz, MsC · kils 7 aralık University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-05-01
Completion
2023-06-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06187389 on ClinicalTrials.gov